Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 327

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Global reporting of progress towards elimination of hepatitis B and hepatitis C

Open access
Cui, Fuqiang, Blach, Sarah, Manzengo Mingiedi, Casimir, Gonzalez, Monica Alonso, Sabry Alaama, Ahmed, Mozalevskis, Antons, Séguy, Nicole, Rewari, Bharat Bhushan, Chan, Po-Lin, Le, Linh-vi, Doherty, Meg, Luhmann, Niklas, Easterbrook, Philippa, Dirac, Mae, de Martel, Catherine, Nayagam, Shevanthi, Hallett, Timothy B, Vickerman, Peter, Razavi, Homie, Lesi, Olufunmiayo, Low-beer, Daniel · 2023 · The Lancet Gastroenterology & Hepatology

Abstract

BACKGROUND: The 69th World Health Assembly endorsed the global health sector strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030. Achieving and measuring the 2030 targets requires a substantial increase in the capacity to test and treat viral hepatitis infections and a mechanism to monitor the progress of hepatitis elimination. This study aimed to identify the gaps in data availability or quality and create a new mechanism to monitor the progress of hepatitis elimination. METHODS: In 2020, using a questionnaire, we collected empirical, systematic, modelled, or surveyed data-reported by WHO country and WHO regional offices-on indicators of progress towards elimination of viral hepatitis, including burden of infection, incidence, mortality, and the cascade of care, and validated these data. FINDINGS: WHO received officially validated country-provided data from 130 countries or territories, and used partner-provided data for 70 countries or territories. We estimated that in 2019, globally, 295·9 million (3·8%) people were living with chronic hepatitis B virus (HBV) infection and 57·8 million (0·8%) people were living with chronic hepatitis C virus (HCV) infection. Globally, there were more than 3·0 million new infections with HBV and HCV and more than 1·1 million deaths due to the viruses in 2019. In 2019, 30·4 million (95% CI 24·3-38·0) individuals living with hepatitis B knew their infection status and 6·6 million (5·3-8·3) people diagnosed with hepatitis B received treatment. Among people with HCV infection, 15·2 million (95% CI 12·1-19·0) had been diagnosed between 2015 and 2019, and 9·4 million (7·5-11·7) people diagnosed with hepatitis C infection were treated with direct-acting antiviral drugs between 2015 and 2019. INTERPRETATION: There has been notable global progress towards hepatitis elimination. In 2019, 30·4 million (10·3%) people living with hepatitis B knew their infection status, which was slightly higher than in 2015 (22·0 million; 9·0%), and 6·6 million (22·7%) of those diagnosed with hepatitis B received treatment, compared with 1·7 million (8·0%) in 2015. Mortality from hepatitis C has declined since 2019, driven by an increase in HCV treatment ten times that of the strategy baseline. However, an estimated 89·7% of HBV infections and 78·6% of HCV infections remain undiagnosed. A new global strategy for 2022-30, based on these new estimates, should be implemented urgently to scale up the screening and treatment of viral hepatitis. FUNDING: World Health Organization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(22)00386-7

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 327

Metadata

Authors
Cui, F., Blach, S., Manzengo Mingiedi, C., Gonzalez, M. A., Sabry Alaama, A., Mozalevskis, A., Séguy, N., Rewari, B. B., Chan, P.-L., Le, L.-V., Doherty, M., Luhmann, N., Easterbrook, P., Dirac, M., de Martel, C., Nayagam, S., Hallett, T. B., Vickerman, P., Razavi, H., Lesi, O., & Low-beer, D.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2023-04
Volume
8
Issue
4
Pages
332-342
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W4319336161
Cited by
327
References
10
FWCI
54.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global reporting of progress towards elimination of hepatitis B and hepatitis C. https://app.cochat.ai/papers/10.1016/s2468-1253(22)00386-7
The paper
Cui, F., Blach, S., Manzengo Mingiedi, C., Gonzalez, M. A., Sabry Alaama, A., Mozalevskis, A., Séguy, N., Rewari, B. B., Chan, P.-L., Le, L.-V., Doherty, M., Luhmann, N., Easterbrook, P., Dirac, M., de Martel, C., Nayagam, S., Hallett, T. B., Vickerman, P., Razavi, H., . . . Low-beer, D. (2023). Global reporting of progress towards elimination of hepatitis B and hepatitis C. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(22)00386-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.